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Lipids comprise a wide variety of  substances 
that share the common feature of being 
insoluble in water but soluble in organic 
solvents. Fatty acids are important building 
blocks of lipids and they give a diversity and 
chemical specificity to the complex lipids 
found in natural fats and oils, comparable 
to that given by the amino acids to pro-
teins. Because of their special characteristics 
and significance, fatty acids are commonly 
treated as a separate group. Together, fatty 
acids and lipids are increasingly being rec-
ognized as serving important roles in physi-
ology. Thus, fatty acids and lipids serve as 
membrane constituents and in energy supply 
and fuel storage, but specific lipids also func-
tion in regulating a wide variety of cellular 
processes, including gene expression. The 
most notable example is that long-chain 
fatty acids and some oxygenated deriva-
tives can bind and thereby activate nuclear 
receptor proteins, in particular the so-called 
peroxisome proliferator activated receptors 
(PPARs), which in turn influence the expres-
sion of specific genes like those involved in 
lipid metabolism. In this way, fatty acids act 
as signaling molecules regulating the cellu-
lar routes and capacity for lipid utilization. 
Within this context, also the role of retinoic 
acid, a derivative of vitamin A, as a major 
regulator of gene expression should be men-
tioned. Another development is the finding 
that the level of lipid storage, for instance 
in adipose tissue, can be sensed by specific 
compounds. The corollary is that lipid drop-
lets can no longer be viewed as inert intra-
cellular deposits but rather appear dynamic 
structures able to communicate with other 
intracellular compartments. Taken together, 
a dynamic interplay among lipids, proteins, 
and membranes is of central importance for 
the proper physiological regulation of cellu-
lar functions. Below, I will highlight examples 
of new developments in this exciting field 
together with challenges for future research.
Biological memBranes
The function and properties of membranes 
are to a great extent determined by the chem-
ical structure of their lipid  components, 
their orientation in the  membrane and 
interaction with other membrane constit-
uents, in particular membrane-associated 
proteins. The discovery of specific mem-
brane lipid domains such as lipid rafts has 
added another level of complexity and regu-
lation of the functioning of membranes and 
membrane-related processes, in particular 
signaling events. Lipid rafts are fluctuat-
ing nanoscale assemblies of sphingolipid, 
cholesterol, and proteins that can be sta-
bilized to coalesce, forming platforms that 
function in membrane signaling and traf-
ficking (Lingwood and Simons, 2010). For 
instance, in the secretory pathway, sorting of 
not only proteins but also lipids has to occur 
before exit from the trans-Golgi network. 
Selective lateral segregation of membrane 
proteins and lipids is thought to be a key 
event in promoting membrane bending and 
subsequent budding to form transport vesi-
cles. Similarly, caveolae, plasma membrane 
invaginations that form a subdomain of 
lipid rafts, function in endocytosis, trans-
cytosis, and regulation of various signaling 
events (Lajoie and Nabi, 2010). Interestingly, 
ω-3 fatty acids have been shown to alter 
caveolae composition and thereby modify 
endothelial function (Layne et al., 2011), 
indicating that caveolae represent a regula-
tory platform for nutritional modulation.
Fatty acid and lipid transport
The hydrophobic nature of (long-chain) 
fatty acids and lipids dictates specific 
requirements to their transport in aqueous 
solutions. In blood plasma, fatty acids are 
avidly bound by albumin while lipids are 
transported in lipoproteins such as chy-
lomicrons and very-low density lipoprotein 
(VLDL). With respect to the mechanism 
of cellular uptake of fatty acids, it has been 
shown that the lipid bilayer of the plasma 
membrane does not represent a barrier 
for fatty acids (Hamilton, 2007). However, 
several membrane-associated fatty acid-
binding proteins (FABPs) have been iden-
tified and shown to markedly accelerate 
cellular fatty acid uptake. These mem-
brane proteins (often referred to as “fatty 
acid  transporters”) function not only in 
facilitating but also in regulating fatty acid 
entry into the cell. This is currently viewed 
to occur by adsorbing fatty acids from the 
extracellular media, modulating their trans-
port into the membrane, and segregating or 
organizing fatty acids for metabolism (Glatz 
et al., 2010). In addition, one of these fatty 
acid transporters, i.e., CD36, was found to 
regulate fatty acid uptake in muscle by a 
mechanism that resembles that of GLUT4-
mediated cellular glucose uptake. Thus, 
following an acute stimulus (insulin, mus-
cle contraction) CD36 translocates from 
an intracellular store (endosomes) to the 
plasma membrane. This recycling of CD36, 
together with the similar recycling of the 
glucose transporter GLUT4, appear to be 
pivotal for the proper regulation of cellu-
lar substrate uptake, for instance to clear 
lipids from the circulation postprandially 
and to rapidly facilitate substrate provision 
when the metabolic demands of muscle 
are increased by contractile activity (Glatz 
et al., 2010). Recent data indicate that this 
function of CD36 is controlled not only 
by intracellular recycling but also by post-
translational modification, in particular 
N-glycosylation (Lauzier et al., 2011).
Intracellular transport of fatty acids and 
lipids is facilitated by specific proteins, such 
as the abundantly expressed (cytoplasmic) 
FABPs (Storch and Corsico, 2008). Members 
of this latter group of proteins appear to be 
involved in trafficking their ligands within 
the cytosol via interactions with organelle 
membranes and specific intracellular pro-
teins. In addition, some members of the 
FABP family of proteins have been shown 
to function directly in the regulation of 
cognate nuclear transcription factor activity 
via ligand-dependent translocation to the 
nucleus and, therefore, may modulate, for 
instance, PPAR-regulation of gene expres-
sion. Taken together, a number of proteins 
are involved in the transport of fatty acids 
and lipids throughout the body, and in 
this way determine their availability and 
functioning. Such controlled  availability is 
important because fatty acids, largely due 
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expected to provide a powerful approach 
to understanding lipid biology (Brown and 
Murphy, 2009). In a recent study, more than 
500 lipids representing the major species of 
the sphingolipid, glycerolipid, glycerophos-
pholipid, fatty acyl, sterol, and prenol classes 
present in human plasma were quantified 
by a “targeted lipidomic” strategy to pro-
vide a base for future studies to character-
ize their relationship to human physiology, 
nutrition, and disease (Quehenberger et al., 
2010). Also in the above-mentioned field 
of the metabolic syndrome, lipidomics has 
now begun to be applied to gain new insight 
(Meikle and Christopher, 2011).
conclusion
Among the various biological molecules 
that comprise the human body, i.e., nucleic 
acids, amino acids, carbohydrates, and 
lipids, lipids stand out in the sheer number 
of distinct molecular species. Lipids serve 
essential roles in many aspects of human 
functioning. In fact, it has become increas-
ingly difficult to find (patho)physiologi-
cal processes in which lipids do not play 
important, if not central, roles as signaling 
and regulatory molecules. The challenge 
of this field is to gain further insight into 
the dynamic interplay both among the 
lipid molecular species and among lipids, 
proteins, and biological membranes. The 
latter includes not only lipids interacting 
with proteins, but also lipid-modifica-
tion of proteins, e.g., post-translational 
N-myristoylation (Martin et al., 2011), 
which adds another level of functional-
ity to many proteins. The still expanding 
availability of research models, such as cel-
lular models and transgenic rodents, and 
of novel analytical methodologies, such 
as high-resolution mass spectroscopy, will 
dramatically accelerate the generation of 
new data. Subsequently it will become cru-
cial to discuss these data properly and to 
disclose the physiological significance of 
the observations. As an example, human 
plasma has been reported to contain thou-
sands of distinct lipid molecular species 
distributed among the main lipid catego-
ries (Quehenberger et al., 2010). Given the 
powerful analytical tools currently available 
and the expected further improvement of 
these techniques in the near future, it will 
be a major challenge to discern the roles 
of individual lipids in health and disease 
before future blood tests will include 
Fatty acids and lipids in disease: 
the metaBolic syndrome
In several chronic diseases such as cardio-
vascular and neurodegenerative diseases 
with genetic and lifestyle components (e.g., 
dietary factors), there is also a perturbed 
lipid metabolism. An example that cur-
rently receives world-wide attention is the 
so-called metabolic syndrome, defined as a 
clustering of multiple metabolic abnormali-
ties based on central obesity and insulin-
resistance. The significance of the metabolic 
syndrome is its close association with the 
risk of type 2 diabetes and cardiovascular 
disease. The current obesity epidemic has 
led to a strong increase in the prevalence 
of type 2 diabetes and, in turn, in its car-
diovascular complications. Thus, obesity is 
characterized by disturbances in the con-
trol of glucose and fat metabolism which is 
associated with an atherogenic lipid profile 
in blood and with deleterious fat accumula-
tion in non-adipose tissues like liver, heart, 
and muscle (ectopic fat deposition). As a 
consequence, individuals suffering from 
these abnormalities are at high risk for 
developing cardiovascular complications, 
including stroke, myocardial infarction, and 
kidney failure (Kassi et al., 2011). Further 
understanding the regulation of whole-
body lipid metabolism, its perturbations 
in obesity and insulin-resistance, and the 
cause of this cascade of adverse events even-
tually leading to cardiovascular disease, is 
expected to help design strategies to prevent 
(e.g., lifestyle intervention) and treat this 
chronic metabolic disorder. For instance, 
one of the issues currently heavily debated 
is whether ω-3 polyunsaturated fatty acids 
(EPA, DHA) have beneficial health effects or 
that caution should be taken with their rec-
ommendation, because of possible adverse 
(e.g., pro-arrhythmic) effects (Saravanan 
et al., 2010).
lipidomics
Over the past decade, the “omics” evolu-
tion has expanded to embrace lipidomics 
as a major contributor to our understand-
ing of biological processes in health and 
disease (Meikle and Christopher, 2011). 
Lipidomics refers to the identification 
and quantification of the many distinct 
molecular species, using state-of-the-art 
approaches made possible by newly devel-
oped instrumentation, protocols, and bio-
informatics tools. As such, lipidomics is 
to their hydrophobic properties, also exert 
harmful effects and may cause (acute) cel-
lular injury.
lipid sensing and lipid sensors
Exciting new insights have been obtained 
in the field of lipid sensing. Besnard and 
colleagues disclosed that the membrane 
protein CD36 functions as an oral sensor 
for long-chain fatty acids (Passily-Degrace 
et al., 2009). Taste cells express CD36 which 
interacts with unsaturated fatty acids, result-
ing in enhanced pancreatobiliary excretions, 
indicating interorgan signaling to prepare 
for the digestion of increased dietary fat. In 
addition, as mentioned above, there now is 
clear evidence that the body is capable of 
sensing the amount of lipid stored in adi-
pocytes (Dugail and Hajduch, 2007).
Fatty acids and lipids in signaling 
pathways
In the last decades a host of new knowledge 
has become available on signal transduc-
tion pathways regulating cellular function-
ing. Among the molecules that participate 
in those signal chains lipids and lipid 
derivatives constitute a major portion. For 
instance, phosphatidylinositol and related 
compounds are involved in a number of 
important intracellular events, e.g., in 
insulin signaling. With respect to cell–cell 
communication, the term lipid mediators 
has been introduced to denote a class of 
bioactive lipids that are produced locally 
through biosynthetic pathways in response 
to extracellular stimuli, are then seques-
tered to transmit signals to target cells by 
interacting with specific receptors. Lipid 
mediators thus can be regarded as (local) 
hormones (Murakami, 2011). The various 
lipid mediators comprise arachidonic acid-
derived eicosanoids, including prostaglan-
dins, leukotrienes, and related compounds, 
lysophospholipids and derivatives such as 
platelet-activating factor and also includ-
ing endocannabinoids, and finally the newly 
identified anti-inflammatory lipid media-
tors derived from ω-3 polyunsaturated fatty 
acids, i.e., resolvins (derived from eicosap-
entaenoic fatty acid, EPA) and protectins 
(derived from docosahexaenoic fatty acid, 
DHA; Ariel and Serhan, 2007). It is clear 
that lipid mediators not only play an essen-
tial role in sustaining homeostasis, but also 
function in pathogenic mechanisms includ-
ing the inflammatory response.
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their routine assessment. The intention of 
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is to provide a forum for in-depth discus-
sion of such new research findings in this 
exciting area.
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